Shawn Marie LaCasse

Title: The Innovative Contributions of Shawn Marie LaCasse

Introduction

Shawn Marie LaCasse is a notable inventor based in Griswold, Connecticut. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patent. His work focuses on the development of compounds that can aid in treating various diseases and conditions.

Latest Patents

LaCasse holds a patent for a compound titled "Crystalline 2-amino-2-(hydroxymethyl)propane-1,3-diol salt of 4-(4-(1-isopropyl-7-OXO-1,4,6,7-tetrahydrospiro[indazole-5,4'-piperidine]-1′-carbonyl)-6-methoxypryridin-2-YL)benzoic acid." This invention provides the tris salt of the compound as a crystalline anhydrous or tri-hydrate, along with polymorphs, pharmaceutical compositions, dosage forms, and their use in treating diseases modulated by the inhibition of an acetyl-CoA carboxylase (ACC) enzyme in animals. LaCasse's patent represents a significant advancement in pharmaceutical research.

Career Highlights

Shawn Marie LaCasse is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His role at Pfizer allows him to contribute to groundbreaking research and development in the pharmaceutical industry. His expertise and innovative mindset have positioned him as a valuable asset to the company.

Collaborations

LaCasse has collaborated with several talented individuals in his field, including Dilinie Fernando and Kristin Elizabeth Price Wiglesworth. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of innovative solutions.

Conclusion

Shawn Marie LaCasse's contributions to the field of pharmaceuticals through his patent and work at Pfizer Corporation highlight his dedication to innovation and research. His efforts in developing new compounds have the potential to make a significant impact on the treatment of various diseases.